Copyright
©The Author(s) 2016.
World J Gastroenterol. Sep 14, 2016; 22(34): 7645-7659
Published online Sep 14, 2016. doi: 10.3748/wjg.v22.i34.7645
Published online Sep 14, 2016. doi: 10.3748/wjg.v22.i34.7645
Table 1 Variables included in the most widely used hepatocellular carcinoma staging systems
Staging system | Ascites | Tumor burden | Albumin | Bilirubin | INR | HE | AFP | PVT | EHS | PS | ALP |
Okuda | Yes | Yes | Yes | Yes | No | No | No | No | No | No | No |
CLIP | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | No | No | No |
BCLC | Yes | Yes | Yes | Yes | Yes | Yes | No | Yes | Yes | Yes | No |
GRETCH | No | No | No | Yes | No | No | Yes | Yes | No | Yes | Yes |
TNM 7th edition | No | Yes | No | No | No | No | No | Yes | Yes | No | No |
- Citation: Colagrande S, Inghilesi AL, Aburas S, Taliani GG, Nardi C, Marra F. Challenges of advanced hepatocellular carcinoma. World J Gastroenterol 2016; 22(34): 7645-7659
- URL: https://www.wjgnet.com/1007-9327/full/v22/i34/7645.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i34.7645